{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:05:55Z","timestamp":1784264755767,"version":"3.55.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (pulmonary MALT lymphoma) is an indolent B-cell lymphoma that can mimic infection, inflammatory disease, or epithelial malignancy. Indeterminate fluorodeoxyglucose-avid abnormalities may complicate staging and lead to overinterpretation of disease extent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 49-year-old man with no smoking history underwent video-assisted thoracoscopic right lower-lobe superior segmentectomy for a 12 \u00d7 9\u00a0mm pulmonary nodule. Histopathology and immunohistochemistry supported pulmonary MALT lymphoma, and fluorescence\n                      <jats:italic>in situ<\/jats:italic>\n                      hybridization detected a\n                      <jats:italic>BIRC3::MALT1<\/jats:italic>\n                      (formerly API2-\n                      <jats:italic>MALT1<\/jats:italic>\n                      ) fusion in 35% of analyzed cells. Resection margins were negative; the only separately documented LN7 lymph node showed reactive hyperplasia without lymphoma, and bone marrow examination was negative. PET\/CT performed 11 days after surgery showed expected postoperative inflammatory uptake, mildly avid right upper-lobe ground-glass opacities (SUVmax 1.0), and circumferential thickening of the horizontal duodenum (SUVmax 4.0). Review of serial preoperative CT reports showed that the additional right-lung ground-glass opacities had been present since at least January 2021 and were largely stable through March 2025. Gastroscopy showed no duodenal mucosal abnormality, no biopsy was obtained, and the duodenal finding remained essentially unchanged after rituximab-based systemic therapy. The minimum confirmed extent was therefore a resected pulmonary MALT lymphoma without proven nodal, marrow, additional pulmonary, or gastrointestinal involvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mild FDG uptake in longstanding pulmonary opacities and an unbiopsied gastrointestinal abnormality should not be interpreted as lymphoma dissemination. Histopathology, immunophenotyping, molecular testing, longitudinal imaging, and pathologic confirmation of suspected additional sites should be integrated before disease extent and treatment response are assigned.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1887841","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:24:04Z","timestamp":1784262244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: pulmonary MALT lymphoma with BIRC3::MALT1 fusion and indeterminate PET\/CT findings"],"prefix":"10.3389","volume":"16","author":[{"given":"Hongliang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Xiangyang No.1 People\u2019s Hospital, Hubei University of Medicine","place":["Xiangyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Xiangyang No.1 People\u2019s Hospital, Hubei University of Medicine","place":["Xiangyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i1.153","article-title":"Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas","volume":"14","author":"Uhl","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bjh.12730","article-title":"Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site","volume":"165","author":"Khalil","year":"2014","journal-title":"Br J Haematol"},{"key":"B3","article-title":"Clinical characteristics, treatment patterns, and survival outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma in the United States","volume":"15","author":"Lin","year":"2023","journal-title":"Am J Transl Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.02.013","article-title":"Pulmonary MALT lymphoma: imaging findings in 18 cases and the associated pathological correlations","volume":"364","author":"Wu","year":"2022","journal-title":"Am J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071742","article-title":"Extranodal marginal zone lymphoma: pathogenesis, diagnosis and treatment","volume":"14","author":"Di Rocco","year":"2022","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2022-0521-OA","article-title":"Usefulness and limitations of current diagnostic strategies for pulmonary mucosa-associated lymphoid tissue lymphoma: lessons learned from a large cohort","volume":"148","author":"Fraune","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2024.105683","article-title":"Marginal zone lymphoma of extranodal sites: a review with an emphasis on diagnostic pitfalls and differential diagnosis with reactive conditions","volume":"156","author":"Segura-Rivera","year":"2025","journal-title":"Hum Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198946","article-title":"Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-\u03baB activation","volume":"331","author":"Rosebeck","year":"2011","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.11.001","article-title":"PET\/CT in non-hodgkin lymphoma: an update","volume":"53","author":"Zanoni","year":"2023","journal-title":"Semin Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06915-3","article-title":"EANM\/SNMMI guideline\/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0","volume":"52","author":"Abikhzer","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14309\/ajg.0000000000002100","article-title":"ACG clinical guideline: diagnosis and management of gastrointestinal subepithelial lesions","volume":"118","author":"Jacobson","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezae064","article-title":"The prognosis of patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma: treated with surgery or chemotherapy","volume":"65","author":"Ning","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26715","article-title":"Revised MALT-IPI: a new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma","volume":"97","author":"Alderuccio","year":"2022","journal-title":"Am J Hematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12957-024-03500-8","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma: insights from a 15-year study at a single institution involving 14 clinical cases","volume":"22","author":"Liao","year":"2024","journal-title":"World J Surg Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1887841\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:24:06Z","timestamp":1784262246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1887841\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":15,"alternative-id":["10.3389\/fonc.2026.1887841"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1887841","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1887841"}}